NJ BIO INC
NJ Bio is seeking a highly skilled Bioconjugation Scientist to independently plan and execute bioconjugation workflows for Antibody-Drug Conjugates (ADCs) and Antibody-Oligo Conjugates (AOCs). The role involves purifying and characterizing bioconjugates using analytical techniques, maintaining laboratory documentation, and managing project timelines under minimal supervision. The successful candidate will collaborate cross-functionally with internal departments and external partners to ensure project success and compliance with safety protocols.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NJ BIO INC.
Scientist II, Bioconjugation Chemist
biomarin
Research Associate Bioconjugation
WayUp
Scientist III - Bioconjugation (ADC) Process Development
Exelixis
Senior Scientist I, ADC/AOC Conjugation
AbbVie
Post-Doctoral Scientist, Bioconjugation Process Innovation
Eli Lilly and Company
Scientist I
Atrium Therapeutics